HHH. Herfarth

H. Herfarth

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


H. Herfarth has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nuclear factor-κB activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin

    by H. Herfarth, K. Brand, H. C. Rath, G. Rogler, J. Schölmerich, W. Falk

    In acute DSS‐induced colitis nuclear factor (NF)‐κB‐dependent inflammatory cytokines including IL‐1 and tumour necrosis factor‐alpha (TNF‐α) are up‐regulated. Here we examined the effects of gliotoxin, a fungal metabolite known to inhibit NF‐κB activity, on cytokine production by a mouse cell system in vitro and on intestinal inflammation and NF‐κB activation in vivo. In vitro gliotoxin decreased TNF‐α gene expression and protein production by RAW‐264.7 mouse macrophage‐like cells stimulated with lipopolysaccharide. In vivo, gliotoxin treatment of mice was begun on day 3 of 5% DSS application dissolved in the drinking water and continued until day 8. Gliotoxin treatment dose‐dependently down‐regulated colonic inflammation as assessed histologically and in parallel there was a suppression of colonic TNF‐α and IL‐1α mRNA expression on day 8 as analysed by semiquantitative reverse transcriptase‐polymerase chain reaction (P < 0·01). Furthermore, colonic NF‐κB DNA‐binding activity was increased in DSS‐induced colitis and was suppressed by gliotoxin. These results demonstrate the essential role of NF‐κB in DSS‐induced colitis and indicate a molecular approach to the treatment of intestinal inflammatory disorders.